1.Doubova SV, Morales HR, Hernández SF, del Carmen Martínez-García M, de Cossío Ortiz MG, Soto MAC, et al. Effect of a Psidii guajavae folium extract in the treatment of primary dysmenorrhea: a randomized clinical trial. Journal of ethnopharmacology. 2007;110(2):305–10.
2.Dawood M. Dysmenorrhoea and prostaglandins: pharmacological and therapeutic considerations. Drugs. 1981;22(1):42–56.
3.Iacovides S, Avidon I, Baker FC. What we know about primary dysmenorrhea today: a critical review. Human reproduction update. 2015;21(6):762–78.
4.Dawood M. Hormones, prostaglandins, and dysmenorrhea. Dysmenorrhea. 1981:21–52.
5.Kannan P, Cheung K-K, Lau BW-M. Does aerobic exercise induced-analgesia occur through hormone and inflammatory cytokine-mediated mechanisms in primary dysmenorrhea? Medical hypotheses. 2019;123:50–4.
6.Strömberg P, Åkerlund M, Forsling M, Granström E, Kindahl H. Vasopressin and prostaglandins in premenstrual pain and primary dysmenorrhea. Acta obstetricia et gynecologica Scandinavica. 1984;63(6):533–8.
7.Pickles V. A plain-muscle stimulant in the menstruum. Nature. 1957;180(4596):1198.
8.Roth‐Brandel U, Bygdeman M, Wiqvist N. Effect of Intravenous Administration of Prostaglandin E1 and F2α on the Contractility of the Non‐Pregnant Human Uterus in Vivo. Acta Obstetricia et Gynecologica Scandinavica. 1970;49(S5):19–25.
9.Yang L, Cao Z, Yu B, Chai C. An in vivo mouse model of primary dysmenorrhea. Experimental animals. 2015;64(3):295–303.
10.Bygdeman M, Bremme K, Gillespie A, Lundström V. Effects of the Prostaglandins on the Uterus: Prostaglandins and uterine contractility. Acta Obstetricia et Gynecologica Scandinavica. 1979;58(S87):33–8.
11.Toppozada M. Effects of prostaglandins on the human non-pregnant uterus and ovary. Prostaglandins and fertility regulation: Springer; 1984. p. 27–57.
12.Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arteriosclerosis, thrombosis, and vascular biology. 2011;31(5):986–1000.
13.John W. Baynes MHD. Meidcal Biochemistry. 2nd ed: Elsevier Mosby; 2005.
14.Kannan P, Chapple CM, Miller D, Claydon-Mueller L, Baxter GD. Effectiveness of a treadmill-based aerobic exercise intervention on pain, daily functioning, and quality of life in women with primary dysmenorrhea: A randomized controlled trial. Contemporary clinical trials. 2019;81:80–6.
15.Reed BG, Carr BR. The normal menstrual cycle and the control of ovulation. Endotext [Internet]: MDText. com, Inc.; 2015.
16.MY D. Dysmenorrhea. Endometrium. 1995;6:363–77.
17.Ma H, Hong M, Duan J, Liu P, Fan X, Shang E, et al. Altered cytokine gene expression in peripheral blood monocytes across the menstrual cycle in primary dysmenorrhea: a case-control study. PloS one. 2013;8(2):e55200.
18.Yeh M-L, Chen H-H, So EC, Liu C-F. A study of serum malondialdehyde and interleukin–6 levels in young women with dysmenorrhea in Taiwan. Life sciences. 2004;75(6):669–73.
19.Lasco A, Catalano A, Benvenga S. Improvement of primary dysmenorrhea caused by a single oral dose of vitamin D: results of a randomized, double-blind, placebo-controlled study. Archives of internal medicine. 2012;172(4):366–7.
20.Tamura I, Taketani T, Lee L, Kizuka F, Taniguchi K, Maekawa R, et al. Differential effects of progesterone on COX–2 and Mn-SOD expressions are associated with histone acetylation status of the promoter region in human endometrial stromal cells. The Journal of Clinical Endocrinology & Metabolism. 2011;96(7):E1073-E82.
21.Smith OM, Jabbour HN, Critchley H. Cyclooxygenase enzyme expression and E series prostaglandin receptor signalling are enhanced in heavy menstruation. Human Reproduction. 2007;22(5):1450–6.
22.Dawood MY. Primary dysmenorrhea: advances in pathogenesis and management. Obstetrics & Gynecology. 2006;108(2):428–41.
23.Aganoff JA, Boyle GJ. Aerobic exercise, mood states and menstrual cycle symptoms. Journal of psychosomatic research. 1994;38(3):183–92.
24.Choi PY, Salmon P. Symptom changes across the menstrual cycle in competitive sportswomen, exercisers and sedentary women. British Journal of Clinical Psychology. 1995;34(3):447–60.
25.Dušek T. Influence of high intensity training on menstrual cycle disorders in athletes. Croat Med J. 2001;42(1):79–82.
26.Israel RG, Sutton M, O’Brien KF. Effects of aerobic training on primary dysmenorrhea symptomatology in college females. Journal of American College Health. 1985;33(6):241–4.
27.Vaziri F, Hoseini A, Kamali F, Abdali K, Hadianfard M, Sayadi M. Comparing the Effects of Aerobic and Stretching Exercises on the Intensity of Primary Dysmenorrhea in the Students of Universities of Bushehr. Journal of family & reproductive health. 2015;9(1):23.
28.Golub LJ, Menduke H, WR L. Exercise and dysmenorrhea in young teenagers: A 3-year study. Obstetrics & Gynecology. 1968;32(4):508–11.
29.Mahvash N, Eidy A, Mehdi K, Zahra MT, Mani M, Shahla H. The effect of physical activity on primary dysmenorrhea of female university students. World Applied Sciences Journal. 2012;17(10):1246–52.
30.Matthewman G, Lee A, Kaur JG, Daley AJ. Physical activity for primary dysmenorrhea: a systematic review and meta-analysis of randomized controlled trials. American Journal of Obstetrics & Gynecology. 2018.
31.Kannan P, Claydon LS, Miller D, Chapple CM. Vigorous exercises in the management of primary dysmenorrhea: a feasibility study. Disability & Rehabilitation. 2014(0):1–6.
32.Chia C, Lai J, Cheung P, Kwong L, Lau F, Leung K, et al. Dysmenorrhoea among Hong Kong university students: prevalence, impact, and management. Hong Kong Med J. 2013;19(3):222–8.
33.Hertzog MA. Considerations in determining sample size for pilot studies. Research in nursing & health. 2008;31(2):180–91.
34.Kieser M, Wassmer G. On the use of the upper confidence limit for the variance from a pilot sample for sample size determination. Biometrical journal. 1996;38(8):941–9.
35.Lefebvre G, Pinsonneault O, Antao V, Black A, Burnett M, Feldman K, et al. Primary dysmenorrhea consensus guideline. J Obstet Gynaecol Can. 2005;27(12):1117–46.
36.Ory M, Resnick B, Jordan PJ, Coday M, Riebe D, Garber CE, et al. Screening, safety, and adverse events in physical activity interventions: collaborative experiences from the behavior change consortium. Annals of behavioral medicine. 2005;29(2):20–8.
37.Gulati M, Shaw LJ, Thisted RA, Black HR, Merz CNB, Arnsdorf MF. Heart Rate Response to Exercise Stress Testing in Asymptomatic Women The St. James Women Take Heart Project. Circulation. 2010;122(2):130–7.
38.Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual analog scale for pain (vas pain), numeric rating scale for pain (nrs pain), mcgill pain questionnaire (mpq), short‐form mcgill pain questionnaire (sf‐mpq), chronic pain grade scale (cpgs), short form‐36 bodily pain scale (sf‐36 bps), and measure of intermittent and constant osteoarthritis pain (icoap). Arthritis care & research. 2011;63(S11):S240-S52.
39.Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113(1):9–19.
40.Piper PJ, Vane J, Wyllie J. Inactivation of prostaglandins by the lungs. Nature. 1970;225(5233):600.
41.Eling TE, Ally AI. Pulmonary biosynthesis and metabolism of prostaglandins and related substances. Environmental health perspectives. 1984;55:159–68.
42.Shrestha HK, Beg MA, Burnette RR, Ginther O. Plasma clearance and half-life of prostaglandin F2alpha: a comparison between mares and heifers. Biology of reproduction. 2012;87(1):18, 1–6.
43.Ginther O, Silva L, Araujo R, Beg M. Temporal associations among pulses of 13, 14-dihydro–15-keto-PGF2alpha, luteal blood flow, and luteolysis in cattle. Biology of reproduction. 2007;76(3):506–13.
44.Leon AC, Davis LL, Kraemer HC. The role and interpretation of pilot studies in clinical research. Journal of psychiatric research. 2011;45(5):626–9.
45.Bailey DL, Holden MA, Foster NE, Quicke JG, Haywood KL, Bishop A. Defining adherence to therapeutic exercise for musculoskeletal pain: a systematic review. Br J Sports Med. 2018:bjsports–2017–098742.
46.Marceau LD, Link C, Jamison RN, Carolan S. Electronic diaries as a tool to improve pain management: is there any evidence?: Blackwell Publishing Inc Malden, USA; 2007.
47.Zweben A, Fucito LM, O’Malley SS. Effective strategies for maintaining research participation in clinical trials. Drug information journal. 2009;43(4):459–67.